Dextromethorphan and its salts
Canada Hotlist: Dextromethorphan and its salts
Health Canada lists this ingredient as prohibited for use in cosmetic products.
监管决定及完整条件
- 状态
- Prohibited
- 法律地位
- Official guidance
- 监管摘要
- Health Canada lists this ingredient as prohibited for use in cosmetic products.
- 条件与限制
- A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. 请打开所引用的来源,并适用下方的全市场要求。
物质身份
- 官方来源名称
- Dextromethorphan and its salts
- CAS
- 125-71-3
- EC
- Not supplied in this source row
- 身份映射
- standalone:cas_number
该身份的跨市场概览
本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。
European Union
1 条关联记录
打开支持记录Great Britain
1 条关联记录
打开支持记录Canada
当前记录1 条关联记录
打开支持记录New Zealand
1 条关联记录
打开支持记录ASEAN
1 条关联记录
打开支持记录China
1 条关联记录 · 1 条含特定条件
打开支持记录South Korea
1 条关联记录 · 1 条含特定条件
打开支持记录Brazil
1 条关联记录 · 1 条含特定条件
打开支持记录India
1 条关联记录 · 1 条含特定条件
打开支持记录Saudi Arabia
1 条关联记录
打开支持记录
CAS 125-71-3 的已核实化学信息
Dextromethorphan
Dextromethorphan is a 6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene in which the sterocenters at positions 4a, 10 and 10a have S-configuration. It is a prodrug of dextrorphan and used as an antitussive drug for suppressing cough. It has a role as a oneirogen, a xenobiotic, a prodrug, a neurotoxin, an antitussive, a NMDA receptor antagonist and an environmental contaminant. It is functionally related to a dextrorphan. It is an enantiomer of a levomethorphan. — ChEBI
- IUPAC 名称
- (1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene
- 分子式
- C18H25NO
- 分子量
- 271.4 g/mol
- 精确质量
- 271.193614421 Da
- 单同位素质量
- 271.193614421 Da
- XLogP3
- 3.4
- 拓扑极性表面积
- 12.5 Ų
- 分子复杂度
- 370.0
- 形式电荷
- 0
- 氢键供体
- 0
- 氢键受体
- 2
- 可旋转键
- 1
- 重原子
- 20
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:4470
- ChEBI:CHEBI:92579
- ChEMBL:CHEMBL52440
- EPA DTXSID:DTXSID3022908
- PubMed:22608604
- PubMed:22073096
- PubMed:22066053
- PubMed:22044595
- PubMed:21973086
- PubMed:21867562
- PubMed:21614312
- PubMed:21445282
- PubMed:21436715
- PubMed:21266064
- PubMed:21244712
- PubMed:21175434
高级结构统计
- 已定义的原子立体中心
- 3
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 6
- 三维环
- 4
- 三维疏水基团
- 0
- 三维受体特征
- 1
- 三维供体特征
- 0
- 三维阴离子中心
- 0
- 三维阳离子中心
- 1
- 三维构象异构体
- 2
- 有效三维可旋转键
- 2.6
机器可读的结构标识符
- SMILES
CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC- InChI
InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1- InChIKey
MKXZASYAUGDDCJ-NJAFHUGGSA-N
来自其他科学数据库的证据
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: White to slightly yellow crystalline powder 来源: Hazardous Substances Data Bank (HSDB)
- Melting Point: 122-124 来源: DrugBank
- Melting Point: 109-111 °C 来源: Hazardous Substances Data Bank (HSDB)
- Odor: Odorless 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: 1.5 g/100 mL 来源: DrugBank
- Solubility: Practically insoluble in water 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: Freely soluble in chloroform 来源: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 来源: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral, rapidly absorbed from the gastrointestinal tract. 来源: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 46.8% (36 of 77) of reports. 来源: European Chemicals Agency (ECHA)
- Signal: Danger 来源: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H301 (51.9%): Toxic if swallowed [Danger Acute toxicity, oral] 来源: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 77 reports by companies from 4 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 36 of 77 reports by companies.; There are 3 notifications provided by 41 of 77 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
- Health Effects: Hypertension, shallow respiration. Dextromethorphan can cause other gastrointestinal disturbances. [Wikipedia] 来源: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: IDENTIFICATION AND USE: Dextromethorphan is a white odorless solid crystal or powder. It is an opium alkaloid derivative, which is found in cough and cold preparations. HUMAN STUDIES: Dextromethorphan is a drug of abuse. The main risks associated with dextromethorphan are ataxia, central nervous system (CNS) stimulation, dizziness, lethargy and psychotic behavior. Less frequently with large doses seizures and respiratory depression can occur. Nausea, vomiting, constipation and tachycardia may also occur. CNS effects include ataxia, drowsiness, vertigo and rarely coma. CNS stimulation may be observed. Restlessness, increased muscle tone with body rigidity have been reported. With extremely large ingestions respiratory depression can occur. Gastrointestinal effects include nausea, vomiting, constipation and dry mouth. Urinary retention may be seen. Dextromethorphan abuse has been described and produces euphoria, CNS stimulation, visual and/or auditory hallucinations. Dextromethorphan hydrobromide is the drug form, thus the possibility of bromide poisoning should be considered in the long term abuser. Dextromethorphan enhances serotonin activity by inhibiting the reuptake of serotonin 来源: Hazardous Substances Data Bank (HSDB)
- Toxicity Summary: Signs and Symptoms of Overdose; One significant concern regarding dextromethorphan toxicity is its OTC misuse, which has steadily increased since the early 2000s. This misuse is referred to by slang terms such as "going pharming," "robotripping," and "dexing." In 2006, three specific OTC product formulations accounted for 66% of reported dextromethorphan misuse cases in the United States, with Coricidin HBP Cough & Cold Tablets and Robitussin products being prominent. A life-threatening toxicity associated with dextromethorphan abuse is serotonin syndrome, resulting from its serotonin reuptake inhibition properties. When combined with SSRIs or MAOIs, the risk of serotonin syndrome increases significantly. Symptoms include agitation, confusion, dilated pupils, headache, tachycardia, hypotension, high fever, seizures, irregular heartbeat, and may progress to unconsciousness.; Despite the rise in misuse, public health efforts and legislative actions restricting the sale of dextromethorphan-containing products to minors have helped stabilize or reduce abuse rates in recent years. However, continued vigilance is essential to prevent misuse and associated toxicities, given dextromethorph 来源: StatPearls
- Toxicity Summary: Dextromethorphan is an opioid-like drug that binds to and acts as antagonist to the NMDA glutamatergic receptor, it is an agonist to the opioid sigma 1 and sigma 2 receptors, it is also an alpha3/beta4 nicotinic receptor antagonist and targets the serotonin reuptake pump. Dextromethorphan is rapidly absorbed from the gastrointestinal tract, where it enters the bloodstream and crosses the blood-brain barrier. The first-pass through the hepatic portal vein results in some of the drug being metabolized into an active metabolite of dextromethorphan, dextrorphan, the 3-hydroxy derivative of dextromethorphan. 来源: Toxin and Toxin Target Database (T3DB)
- Environmental Bioconcentration: The estimated pKa of dextromethorphan is 9.8(1), indicating that dextromethorphan will exist almost entirely in the cation form at pH values of 5 to 9 and, therefore, bioconcentration in fish is not expected to be an important fate process(SRC). 来源: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 23,000(SRC), determined from a structure estimation method(2), indicates that dextromethorphan is expected to be immobile in soil(SRC). The estimated pKa of dextromethorphan is 9.8(3), indicating that this compound will exist almost entirely in the cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization of the cation from moist soil is not expected because cations do not volatilize(SRC). Dextromethorphan is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 1.0X10-5 mm Hg at 25 °C(SRC), determined from a fragment constant method(2). Biodegradation data in soil were not available(SRC, 2017). 来源: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 23,000(SRC), determined from a structure estimation method(2), indicates that dextromethorphan is expected to adsorb to suspended solids and sediment(SRC). An estimated pKa of 9.8(3) indicates dextromethorphan will exist almost entirely in the cation form at pH values of 5 to 9 and, therefore, volatilization from water surfaces and bioconcentration in aquatic organisms are not expected to be an important fate processes(SRC). Dextromethorphan is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(4). Biodegradation data in water were not available(SRC, 2017). 来源: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), dextromethorphan, which has an estimated vapor pressure of 1.0X10-5 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase dextromethorphan is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 3.3 hours(SRC), calculated from its rate constant of 1.2X10-10 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(2). Particulate-phase dextromethorphan may be removed from the air by wet or dry deposition(SRC). Dextromethorphan contains chromophores that absorb at wavelengths >290 nm(3) and, therefore, is expected to be susceptible to direct photolysis by sunlight(SRC). 来源: Hazardous Substances Data Bank (HSDB)
- Uses: Antitussive Agents; Excitatory Amino Acid Antagonists 来源: Hazardous Substances Data Bank (HSDB)
- Uses: Probe to determine cytochrome 450 phenotype 来源: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION 来源: Hazardous Substances Data Bank (HSDB)
- Uses: Dextromethorphan (DXM) is an over-the-counter (OTC) cough suppressant commonly found in cold medications. DXM is often abused in high doses by adolescents to generate euphoria and visual and auditory hallucinations. Illicit use of DXM is referred to on the street as "Robo-tripping" or "skittling." These terms are derived from the most commonly abused products, Robitussin and Coricidin. 来源: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >1000; Use (kg) in USA (2002): 38000; Consumption (g per capita; approx.) in Germany (2009): 0.0122; Consumption (g per capita) in the USA (2002): 0.135; Excretion rate: 0.25; Calculated removal (%): 45.3 来源: NORMAN Suspect List Exchange
- Uses: The primary use of dextromethorphan is as a cough suppressant, for the temporary relief of cough caused by minor throat and bronchial irritation (as commonly accompanies the common cold), as well as those resulting from inhaled irritants. In addition, a combination of dextromethorphan and quinidine has been shown to alleviate symptoms of easy laughing and crying (pseudobulbar affect) in patients with amyotrophic lateral sclerosis and multiple sclerosis. 来源: Toxin and Toxin Target Database (T3DB)
映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录
科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。
其他来源的覆盖范围和匹配状态
| 来源 | 结果 | 已检查 |
|---|---|---|
| NIH PubChem PUG-View | 精确匹配 | 2026-08-31 |
已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与出处
- 已登记来源
- Health Canada Cosmetic Ingredient Hotlist
- 来源参考
- Hotlist prohibited entry 188
- 来源记录 ID
prohibited:188- 来源版本
- Health Canada Hotlist 2025-08-13
- 来源语言
- English
- 翻译状态
- Original is English
- 来源更新
- 2025-08-13
- 快照检查时间
- 2026-08-30 04:07 UTC
- 验证方法
- strict HTML tables t1=490 and t2=90
- SHA-256
8b52ff573d08373ee90121f6a701b3607e4a3d6fc748a7d56171eb53510af91a
已登记的数据集备注
- 数据集覆盖范围
- Administrative prohibitions, restrictions, conditions and warning requirements
- 权威性说明
- Official Health Canada compliance indicator; not a complete safety clearance
本记录在市场数据集中的位置
Canada 市场背景
Complete Hotlist snapshot
覆盖版本: Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
All prohibited and restricted Hotlist entries, including conditions and warning requirements published in the official list.
核实清单
- Search English/French names and CAS identifiers.
- Apply every restriction, concentration and label warning.
- Check Food and Drugs Act/Cosmetic Regulations requirements.
- Recheck the current Hotlist before notification or sale.
官方市场来源
- Health Canada Cosmetic Ingredient HotlistOfficial Health Canada compliance indicator; not a complete safety clearance
核实工作流程与记录完整性
在将此结果用于合规决定之前
- 确认“Dextromethorphan and its salts”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
- Search English/French names and CAS identifiers.
- Apply every restriction, concentration and label warning.
- Check Food and Drugs Act/Cosmetic Regulations requirements.
- Recheck the current Hotlist before notification or sale.
- 记录来源版本,并在生产、备案或上市之前重新核查监管机构。
本记录中的可用字段
- 官方物质名称可用
- CAS可用
- EC未提供
- 单独的条件文本来源行中不存在
- 生效日期未提供
- 快照哈希与方法可用
本页回答的问题
稳定引用
Dextromethorphan and its salts. Hotlist prohibited entry 188. Canada. Source version Health Canada Hotlist 2025-08-13. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/ca/records/188/
请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。
Canada 的解读与局限
This official record identifies the substance as prohibited for cosmetic use in the stated market scope.
Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.
如何解读法律地位
The authority uses this source as compliance guidance; the underlying legislation remains controlling.
本页证据
- 记录结果:Prohibited
- 法律地位:Official guidance
- 来源版本:Health Canada Hotlist 2025-08-13
它不能证明什么
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
进一步的权威物质研究
这些来源均不能推翻上述市场决定。
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
在来源处研究此身份FDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
在来源处研究此身份ILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
在来源处研究此身份Japan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
在来源处研究此身份NIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
在来源处研究此身份OECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
在来源处研究此身份US EPA CompTox CTX APIs
导入需要 API 密钥DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
在来源处研究此身份